Trevi Therapeutics's chart data is dated 2026-10-08. There is no active technical signal. There are 3 published signal records.
Trevi Therapeutics last closed at $12.82 (-2.40%) on 2026-10-08. Listed on Nasdaq. Trailing 12 months PER is -39.3×. Its overall grade ranks 114 of 738 stocks in Healthcare.
About this company
Trevi Therapeutics last closed at $12.82 (-2.40%) on 2026-10-08. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A · 114/738
Valuation grade A+
Related stocks
- MerckCustomer
treprostinil 계열 개발·상업화 가능성 측면에서 잠재적 파트너/고객 관계
- Johnson & JohnsonCompetitor
호흡기·섬유화 등 대형 제약사로 동일 적응증 영역에서 경쟁 가능
- AstraZenecaCompetitor
호흡기 질환 및 염증·섬유화 치료제 개발에서 경쟁
About Trevi Therapeutics
- What technical signals does Trevi Therapeutics (TRVI) have?
- Trevi Therapeutics current technical signals: no active technical signal.
- Is Trevi Therapeutics a cup-and-handle pattern?
- No. Trevi Therapeutics has no valid Cup signal right now.
- What published figures are available for Trevi Therapeutics?
- Market cap: $1.64B. Trailing 12 months PER: -39.3×. Latest quarter PBR: 6.25×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Trevi Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.